Down-regulation of hepatic and intestinal Abcg5 and Abcg8 expression associated with altered sterol fluxes in rats with streptozotocin-induced diabetes.
OBJECTIVE
Type I diabetes is associated with altered hepatic bile formation and increased intestinal cholesterol absorption. The aim of this study was to evaluate whether altered expression of the ATP-Binding Cassette half-transporters Abcg5 and Abcg8, recently implicated in control of both hepatobiliary cholesterol secretion and intestinal cholesterol absorption, contributes to changed cholesterol metabolism in experimental diabetes.


METHODS
mRNA and protein expression of Abcg5 and Abcg8 were determined in the liver and intestine of rats with streptozotozin-induced diabetes and related to relevant metabolic parameters in plasma, liver and bile.


RESULTS
Hepatic mRNA expression of both Abcg5 (-76%) and Abcg8 (-71%) was reduced in diabetic rats when compared to control rats. In spite of increased HDL cholesterol, considered a major source of biliary cholesterol, secretion of the sterol into bile relative to that of bile salts was reduced by 65% in diabetic animals. Intestinal mRNA expression of Abcg5 (-47%) and Abcg8 (-43%) as well as Abcg5 protein contents were also reduced in insulin-deficient animals. This was accompanied by a three- to four-fold increase in plasma beta-sitosterol and campesterol concentrations and by a doubling of the calculated apparent cholesterol absorption. These effects partially normalized upon insulin supplementation.


CONCLUSIONS
Our data indicate that effects of insulin-deficiency on bile composition and cholesterol absorption in rats are, at least partly, attributable to changes in hepatic and intestinal Abcg5 and Abcg8 expression.
Bloks
V W
VW
Center for Liver, Digestive and Metabolic Diseases, University Hospital Groningen, Groningen, The Netherlands.
Bakker-Van Waarde
W M
WM
Verkade
H J
HJ
Kema
I P
IP
Wolters
H
H
Vink
E
E
Groen
A K
AK
Kuipers
F
F
D000071018:ATP Binding Cassette Transporter, Subfamily G, Member 5; D000071019:ATP Binding Cassette Transporter, Subfamily G, Member 8; D018528:ATP-Binding Cassette Transporters / Q000235:genetics*; D000818:Animals; D016632:Apolipoprotein A-I / Q000378:metabolism; D001646:Bile / Q000378:metabolism; D002784:Cholesterol / Q000031:analogs & derivatives* / Q000097:blood*; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000235:genetics / Q000378:metabolism*; D005786:Gene Expression Regulation; D007413:Intestinal Mucosa / Q000378:metabolism; D008074:Lipoproteins / Q000235:genetics*; D008099:Liver / Q000378:metabolism; D008297:Male; D010840:Phytosterols; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D017208:Rats, Wistar; D012855:Sitosterols / Q000097:blood; D014158:Transcription, Genetic / Q000235:genetics*; D014280:Triglycerides / Q000378:metabolism
D000071018:ATP Binding Cassette Transporter, Subfamily G, Member 5; D000071019:ATP Binding Cassette Transporter, Subfamily G, Member 8; D018528:ATP-Binding Cassette Transporters; C480692:Abcg5 protein, rat; C480693:Abcg8 protein, rat; D016632:Apolipoprotein A-I; D008074:Lipoproteins; D010840:Phytosterols; D012333:RNA, Messenger; D012855:Sitosterols; D014280:Triglycerides; C021273:campesterol; C025473:gamma-sitosterol; D002784:Cholesterol